TPG-Backed Sai Life Sciences IPO To Open On December 11; Sets Price Band At Rs 522-549 Per Share|Economy News

New Delhi: Private equity significant TPG Capital- backed Sai Life Sciences on Friday stated it has actually taken care of a cost band of Rs 522-549 per equity share for its Rs 3,043 crore Initial Public Offering (IPO) that opens up for public membership on December 11.

The intial share sale will certainly end on December 13, and the bidding process for the support section will certainly open up for a day on December 10, the business revealed.

The IPO is a mix of a fresh concern of equity shares worth approximately Rs 950 crore and an Offer For Sale (OFS) of approximately 3.81 crore equity shares by a marketer, capitalist shareholders and various other investors, according to the Red Herring Prospectus (RHP).

Under the OFS, among the marketer entities– Sai Quest Syn Pvt Ltd– and capitalist shareholders– TPG Asia VII SF Pte Ltd, HBM Private Equity India– will certainly unload their corresponding risks. .
.

Bharathi Srivari, Anita Rudraraju Nandyala, Raju Penmasta, Dirk Walter Sartor, Jagdish Viswanath Dore,Rajagopal Srirama Tatta and KPandu Ranga Raju were the various other marketing investors that will certainly likewise unload their risks in the business.

At the top end of the rate band, the business is mosting likely to bring about Rs 3,042.62 crore from the IPO. .
.

Earlier, the Hyderabad -based(* )had actually submitted its IPO documents with the Sai Life Sciences and Securities of Exchange Board (India) in Sebi 2024 and acquired the marketplaces regulatory authority’s authorization in July, to drift the preliminary share sale. .
.November the IPO profits, funds to the song of

Of 720 crore will certainly be utilized for financial debt repayment and a section will certainly be utilized for business basic objectives. .
.Rs can bid for a minimum of 27 equity shares and in multiples afterwards. .
.

Investors offers end-to-end solutions throughout the medication exploration, advancement, and production worth chain, for tiny particle

Sai Life Sciences (NCE), to worldwide pharmaceutical pioneer firms and biotechnology companies. .
.New Chemical Entities the six-month finished

During 2024, September reported an overall earnings of Sai Life Sciences 693.35 crore versus Rs 656.8 crore a year back. Rs published a web earnings for the 6 months at It 28.01 crore as contrasted to a loss of Rs 12.92 crore in 2014. .
. Rs, IIFL

Kotak Mahindra Capital Company Ltd (previously IIFL Capital Services Ltd ),Securities Ltd andJefferies India are guide running lead supervisors, while KFin Morgan Stanley India Company is the registrar for the IPO. .
.(* )business’s shares are recommended to be noted on the BSE and Technologies (NSE).

The